Pembrolizumab-Induced Myositis: Diagnostic and Therapeutic Challenges From Two Case Reports and a Narrative Review [0.03%]
派姆单抗致肌炎：两例报道及文献回顾中的诊断和治疗挑战
Francesca Rifaldi,Niccolò Leandro Alessio,Francesca Caspani et al.
Francesca Rifaldi et al.
Background: Pembrolizumab, an anti-PD-1 immune checkpoint inhibitor, has transformed the treatment of multiple solid tumors. However, it can rarely cause immune-related myositis, which may involve limb, bulbar, and respir...
Case Series: Can Daily Patient-Reported Outcome Measures Be Implemented for Cancer-Related Fatigue? [0.03%]
病例系列：是否可以实施每日患者报告结局测量以应对癌症相关疲劳？
Alexander Tilg,Andreas Meryk,Johannes G Weiss et al.
Alexander Tilg et al.
Background: Cancer-related fatigue (CrF), a prevalent and debilitating symptom among cancer patients, remains underrecognized and unstandardized in routine oncology care. To address this, we introduced a new digital tool ...
Impact of Frontline Treatment Strategies on Outcomes in Patients With Acute Myeloid Leukemia, Myelodysplasia-Related [0.03%]
急性髓系白血病和骨髓增生异常综合征相关疾病的前线治疗策略对患者预后的影响研究
Yi Li,Dian Jin,Peiying Fang et al.
Yi Li et al.
Background: The 5th edition of the World Health Organization (WHO) classification updated the term for acute myeloid leukemia with myelodysplasia-related changes (AML-MRC) to acute myeloid leukemia, myelodysplasia-related...
The Utility of HER2 Overexpression in Prognosis of Gastric Cancer: A Systematic Review and Meta-Analysis Study [0.03%]
HER2高表达在胃癌预后中的作用：系统评价和meta分析研究
Seyed Morteza Pourfaraji,Alireza Abdollahi,Fatemeh Ojaghi Shirmard et al.
Seyed Morteza Pourfaraji et al.
Aim: This systematic review and meta-analysis aimed to clarify the prognostic impact of human epidermal growth factor receptor 2 (HER2) overexpression on overall survival (OS) and progression-free survival (PFS) in advanc...
Assessing Practice Patterns of Antidepressant Medication and Tamoxifen Use Among Patients With Hormone Receptor-Positive Breast Cancer [0.03%]
评估激素受体阳性乳腺癌患者的抗抑郁药和他莫昔芬用药模式实践规律
Nerea Lopetegui-Lia,Alexandra Murray,Mariah Ondeck et al.
Nerea Lopetegui-Lia et al.
Background: Some commonly prescribed antidepressants inhibit CYP2D6, an enzyme that metabolizes tamoxifen into its active metabolite, endoxifen. This inhibition could theoretically decrease the efficacy of tamoxifen, whic...
Dance and Dietary Intervention Improves Metabolic Health, Fitness, and Quality of Life With Modest Gut Microbiota Shifts in Breast Cancer Patients With Obesity: A Pilot RCT [0.03%]
舞蹈和饮食干预可改善肥胖乳腺癌患者的代谢健康、体能和生活质量，并且可以适度改变肠道微生物组：一项初步随机对照试验
Libuša Nechalová,Adela Penesová,Ivan Hric et al.
Libuša Nechalová et al.
Background: Post-treatment weight gain and gut dysbiosis are important concerns in breast cancer patients. However, evidence on the gut microbiota in this population, particularly in relation to physical activity, is limi...
Randomized Controlled Trial
Cancer reports (Hoboken, N.J.). 2026 Jun;9(6):e70611. DOI:10.1002/cnr2.70611 2026
Diabetes and Cancer-Specific Survival: A Nationwide Population-Based Cohort Study Across Multiple Cancer Sites [0.03%]
糖尿病与癌症特异性生存关系：一项基于全国人口的多部位癌症队列研究
Petrus Lohi,Jari Haukka,Leo Niskanen et al.
Petrus Lohi et al.
Background: Cancer patients with concurrent diabetes generally show poorer survival compared with nondiabetic patients. Aims: We examin...
Assessment of Multiple Prognostic Scores in Patients With Metastatic Renal Cell Carcinoma Receiving First-Line, Immune-Based Combinations [0.03%]
评估转移性肾细胞癌患者一线接受免疫联合治疗时多种预后评分的效果
Hiromichi Sakurai,Masanobu Shiga,Shuya Kandori et al.
Hiromichi Sakurai et al.
Background: Combination immunotherapy is widely used as first-line treatment for metastatic renal cell carcinoma (mRCC), but pretreatment prognostic stratification remains insufficiently established. ...
Multicenter Study
Cancer reports (Hoboken, N.J.). 2026 Jun;9(6):e70604. DOI:10.1002/cnr2.70604 2026
Ultrasound and Clinicopathological Features-Based Machine Learning Model for Predicting Neoadjuvant Therapy Efficacy in Breast Cancer [0.03%]
基于超声和临床病理特征的机器学习模型在预测乳腺癌新辅助治疗疗效中的应用
Tongtong Hao,Xiaohui Ji,Qianying Zhao et al.
Tongtong Hao et al.
Background: Accurate prediction of pathological complete response (pCR) after neoadjuvant therapy (NAT) remains challenging in breast cancer. Conventional imaging modalities, such as ultrasound and magnetic resonance imag...
Chiara Maestri,Ivan Trus,Rajeshwar Nitiyanandan et al.
Chiara Maestri et al.
Background: Advanced-stage ovarian cancers exhibit significant variability in responses to standard chemotherapy ranging from platinum-refractory to platinum-sensitive cancers. While genomic testing reveals tissue heterog...